1147014-44-5 Usage
Uses
Used in Medicinal Chemistry and Drug Development:
7H-Pyrrolo[2,3-d]pyrimidine, 4-ethynylis utilized as a precursor or intermediate in the synthesis of pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Organic Synthesis and Chemical Research:
In the realm of organic synthesis, 7H-Pyrrolo[2,3-d]pyrimidine, 4-ethynylserves as a valuable building block for creating more complex molecules. Its ethynyl group and fused heterocyclic rings provide a versatile platform for further chemical modifications and the exploration of novel molecular architectures.
Used in Pharmaceutical Compounds Synthesis:
7H-Pyrrolo[2,3-d]pyrimidine, 4-ethynylis employed in the synthesis of pharmaceutical compounds, where its unique structural features contribute to the development of new therapeutic agents with potential applications in various medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1147014-44-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,7,0,1 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1147014-44:
(9*1)+(8*1)+(7*4)+(6*7)+(5*0)+(4*1)+(3*4)+(2*4)+(1*4)=115
115 % 10 = 5
So 1147014-44-5 is a valid CAS Registry Number.
1147014-44-5Relevant academic research and scientific papers
Solution-phase parallel synthesis of ruxolitinib-derived Janus kinase inhibitors via copper-catalyzed azide-alkyne cycloaddition
Gehringer, Matthias,Forster, Michael,Laufer, Stefan A.
supporting information, p. 5 - 10 (2015/01/30)
A solution-phase parallel synthesis of triazole-derived ruxolitinib analogues was developed in the current study. The method employs copper-catalyzed azide-alkyne cycloaddition to build up the central triazole template. Product isolation by precipitation
PROTEIN KINASE INHIBITORS AND USE THEREOF
-
Page/Page column 26-27, (2011/11/30)
Disclosed are compounds according to Formula I: wherein the variables are described herein.
